Oxprenoate potassium
| Clinical data | |
|---|---|
| Other names | RU-28318; 17α-Hydroxy-3-oxo-7α-propylpregn-4-ene-21-carboxylic acid monopotassium salt | 
| Drug class | Antimineralocorticoid | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C25H37KO4 | 
| Molar mass | 440.665 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Oxprenoate potassium (developmental code name RU-28318) is a synthetic steroidal antimineralocorticoid which was never marketed. The affinities of oxprenoate potassium for the steroid hormone receptors have been reported.